A detailed history of Acadian Asset Management LLC transactions in Geron Corp stock. As of the latest transaction made, Acadian Asset Management LLC holds 27,318 shares of GERN stock, worth $91,515. This represents 0.0% of its overall portfolio holdings.

Number of Shares
27,318
Holding current value
$91,515
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$4.17 - $4.99 $113,916 - $136,316
27,318 New
27,318 $124,000
Q4 2017

Jan 18, 2018

SELL
$1.8 - $2.32 $44,233 - $57,011
-24,574 Closed
0 $0
Q3 2017

Oct 13, 2017

BUY
$1.99 - $2.65 $48,902 - $65,121
24,574
24,574 $54,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.27B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.